Bioengine Technology Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
130
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$43.8M
- Investors
-
11
Bioengine Technology General Information
Description
Developer of a bio-technical platform designed to offer animal cell research and development service. The company focuses on the research and development, and application of critical biotechnologies, including the large-scale high-density serum-free culture of animal cells and personalized serum-free medium raw materials, and provides technical support and key raw material and equipment support for pilot incubation, industrialization, and industrial production of biomedical products, enabling clients to improve biotechnological research efficiency and receive high-quality biomedical treatment.
Contact Information
Website
www.bio-engine.com.cnCorporate Office
- 5F, Building 1, Lane 720, Cailun Road
- Pudong New Area
- Shanghai, 201203
- China
Corporate Office
- 5F, Building 1, Lane 720, Cailun Road
- Pudong New Area
- Shanghai, 201203
- China
Bioengine Technology Timeline
Bioengine Technology Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. Later Stage VC (Series C) | 15-May-2023 | $43.8M | Completed | Generating Revenue | ||
7. Later Stage VC (Series B2) | 29-Mar-2022 | Completed | Generating Revenue | |||
6. Later Stage VC (Series B1) | 06-Jul-2021 | Completed | Generating Revenue | |||
5. Early Stage VC (Series B) | 26-Aug-2019 | Completed | Generating Revenue | |||
4. Early Stage VC (Series A1) | 15-Jun-2018 | Completed | Generating Revenue | |||
3. Early Stage VC (Series A) | 19-Mar-2016 | Completed | Generating Revenue | |||
2. Grant | $2.9M | $162K | Completed | Startup | ||
1. Capitalization | 24-Dec-2014 | $162K | $162K | Completed | Startup |
Bioengine Technology Executive Team (1)
Name | Title | Board Seat |
---|---|---|
Wensong Tan Ph.D | Founder & Chairman |
Bioengine Technology Board Members (1)
Name | Representing | Role | Since |
---|---|---|---|
Wensong Tan Ph.D | Bioengine Technology | Founder & Chairman |
Bioengine Technology Signals
Bioengine Technology Investors (11)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
HM Capital | Venture Capital | Minority | ||
Kington Capital | Venture Capital | Minority | ||
Leo Group Company | Corporation | Minority | ||
NRL Capital | Venture Capital | Minority | ||
Riverhead Capital (China) | Corporate Venture Capital | Minority |
Bioengine Technology FAQs
-
When was Bioengine Technology founded?
Bioengine Technology was founded in 2014.
-
Who is the founder of Bioengine Technology?
Wensong Tan Ph.D is the founder of Bioengine Technology.
-
Where is Bioengine Technology headquartered?
Bioengine Technology is headquartered in Shanghai, China.
-
What is the size of Bioengine Technology?
Bioengine Technology has 130 total employees.
-
What industry is Bioengine Technology in?
Bioengine Technology’s primary industry is Biotechnology.
-
Is Bioengine Technology a private or public company?
Bioengine Technology is a Private company.
-
What is the current valuation of Bioengine Technology?
The current valuation of Bioengine Technology is
. -
What is Bioengine Technology’s current revenue?
The current revenue for Bioengine Technology is
. -
How much funding has Bioengine Technology raised over time?
Bioengine Technology has raised $93.3M.
-
Who are Bioengine Technology’s investors?
HM Capital, Kington Capital, Leo Group Company, NRL Capital, and Riverhead Capital (China) are 5 of 11 investors who have invested in Bioengine Technology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »